Product Liability and the Economics of Pharmaceuticals and Medical Devices

Product Liability and the Economics of Pharmaceuticals and Medical Devices
Author: Steven Garber
Publisher: RAND Corporation
Total Pages: 272
Release: 1993
Genre: Business & Economics
ISBN:

This study examined the economic effects of product liability on firms producing drugs and medical devices. The study found that the liability system enhances the economic contributions of the industries in some ways.

Economic Effects of Product Liability and Other Litigation Involving the Safety and Effectiveness of Pharmaceuticals

Economic Effects of Product Liability and Other Litigation Involving the Safety and Effectiveness of Pharmaceuticals
Author: Steven Garber
Publisher: Rand Corporation
Total Pages: 117
Release: 2013
Genre: Business & Economics
ISBN: 0833079913

Liability effects on the economic performance of the pharmaceutical industry play a prominent role in the debate about the economic effects of product liability in the United States. The author analyzes incentive effects on company decisions, implications for economic outcomes such as drug safety and effectiveness, and suggests how public policy changes could mitigate liability-based sources of inefficient decisions of pharmaceutical companies.

Drug and Device Product Liability Litigation Strategy

Drug and Device Product Liability Litigation Strategy
Author: Mark Herrmann
Publisher: Oxford University Press, USA
Total Pages: 539
Release: 2012
Genre: Law
ISBN: 0199734941

In Drug and Device Product Liability Litigation Strategy, Mark Herrmann and David B. Alden provide useful practice pointers and overall strategic guidance for attorneys in product liability litigation involving prescription drugs and medical devices.

The Law and Economics of Public Health

The Law and Economics of Public Health
Author: Frank A. Sloan
Publisher: Now Publishers Inc
Total Pages: 174
Release: 2007
Genre: Business & Economics
ISBN: 1601980744

The Law and Economics of Public Health synthesizes the empirical research findings on the relationship between law and the public's health that are found scattered in different literature ranging from economic journals to medical journals, journals on addictive behaviors, law reviews, and books. This is the only study to date that has assembled the empirical evidence from many areas ranging from motor vehicle liability and dram shop liability to medical malpractice, products liability as it applies to pharmaceutical products, and medical devices. The Law and Economics of Public Health addresses the fundamental question as to whether or not and the extent to which imposing tort liability on potential injurers improves the public's health. Does the threat of litigation on potential injurers make them exercise more caution? Does insurance coverage counter incentives to be careful? Does the tort system operate as perfectly as the theory would have it? This monograph answers these questions on the basis of empirical evidence. The Law and Economics of Public Health discusses both theory and empirical evidence in several areas of personal injury to which tort liability has been applied. The monograph starts by describing the general law and economics framework used to assess both positive and normative issues relating to tort liability. It then presents the rationale for and empirical evidence on particular applications of tort liability as it applies to personal injury.

Drug Product Liability

Drug Product Liability
Author: Frank C. Woodside
Publisher: LexisNexis
Total Pages:
Release: 1997-01-01
Genre: Drugs
ISBN: 9780820512570

3 Volumes; Looseleaf; updated with supplements & revisions.

The Changing Economics of Medical Technology

The Changing Economics of Medical Technology
Author: Institute of Medicine
Publisher: National Academies Press
Total Pages: 225
Release: 1991-02-01
Genre: Medical
ISBN: 030904491X

Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.

Product Liability, Insurance, and the Pharmaceutical Industry

Product Liability, Insurance, and the Pharmaceutical Industry
Author: Geraint G. Howells
Publisher: Manchester University Press
Total Pages: 240
Release: 1991
Genre: Insurance, Products liability
ISBN: 9780719033742

A collection of papers from the ninth Fulbright Colloquium held in September 1989. The papers compare legal practices and procedures in North America and Europe and the barriers to drug development caused by increased litigation in cases involving pharmaceutical products.

Innovation and the Pharmaceutical Industry

Innovation and the Pharmaceutical Industry
Author: H. Tristram Engelhardt
Publisher: M & M Scrivener Press
Total Pages: 253
Release: 2014-05-14
Genre: Business & Economics
ISBN: 0980209471

Innovation and the Pharmaceutical Industry: Critical Reflections on the Virtues of Profit examines the central role of profit in the development of pharmaceuticals, medical devices, and health care generally. Recent efforts to understand this role have often underestimated and even dismissed its importance, arguing for its replacement by other means and mechanisms. However, as the essays in this volume attest, it would be impossible to account adequately for the range of pharmaceuticals and medical devices that have become part of everyday medicine without recognizing that the depth and scope of innovations are tied not simply to altruism, a concern for the common good, or the pursuit of knowledge for its own sake, but crucially to the pursuit of private good and of individual profit. Balancing a concern for theory and practice, the analyses and evaluations provided in these essays touch directly on many of the most heated and important debates in pharmaceutical ethics, such as profit margins, corporate social responsibility, drug advertising, litigation, patents, and parallel trade. Reflecting critically on the problems and prospects of medical innovation, they invite a rethinking of the foundations of the bioethics and business ethics of the pharmaceutical and medical device industries by focusing on the long-term impact of policy decisions for human health and well-being.